Introduction
Rheb (Ras-homolog enriched in brain) is a member of the Ras superfamily of small G-proteins. It was isolated in a screen for genes that are induced in neurons by synaptic activity (Yamagata et al., 1994) . Subsequent studies revealed that Rheb is expressed in various tissues, but most abundantly in skeletal and cardiac muscles, testes and ovary (Gromov et al., 1995) . The Rheb gene is highly conserved in eukaryotes from yeast to mammals . Rheb shares high homology with human Rap2, yeast RAS1 and human H-Ras (37.7, 43.3 and 34% identity, respectively; Yamagata et al., 1994) . It contains five G boxes that are involved in the recognition and hydrolysis of GTP (Urano et al., 2000) . Biochemical and cell biological evidence suggests that Rheb has a low intrinsic GTPase activity and occurs preferentially in an activated, GTPbound state (Clark et al., 1997; Im et al., 2002) . The tuberous sclerosis complex (TSC), a tumor suppressor formed by the TSC1 (hamartin) and TSC2 (tuberin) proteins, functions as a GTPase-activating protein (GAP) and hence as a negative regulator of Rheb (Castro et al., 2003; Garami et al., 2003; Inoki et al., 2003; Tee et al., 2003; Zhang et al., 2003) . Drosophila translationally controlled tumor protein has recently been identified as the putative guanine nucleotide exchange factor for Rheb in that species (Hsu et al., 2007) .
In yeast, disruption of Rheb causes increased uptake of arginine, whereas hyperactivated Rheb, such as that in TSC1/2 mutant cells, leads to decreased uptake of arginine (Urano et al., 2000; van Slegtenhorst et al., 2004) . In the Drosophila cell line S2 and in Schizosaccharomyces pombe, knockdown of Rheb results in cellcycle arrest in the G 0 /G 1 phase, whereas overexpression of Rheb leads to a significant increase of S-phase cells (Mach et al., 2000; Patel et al., 2003) . Complementary screens for loss-and gain-of-function mutations affecting cell size in Drosophila identified Rheb as an essential regulator of cell size; overexpression of Rheb results in larger cells (Patel et al., 2003; Saucedo et al., 2003; Stocker et al., 2003) .
Genetic and biochemical studies have placed Rheb upstream of target of rapamycin (TOR) and downstream of Akt (v-akt murine thymoma viral oncogene homolog) and TSC1/2 in the PI3K/Akt/TOR/S6K signaling pathway (Castro et al., 2003; Garami et al., 2003; Inoki et al., 2003; Saucedo et al., 2003; Stocker et al., 2003; Tee et al., 2003; Zhang et al., 2003) . In the canonical PI3K/Akt/TOR signaling model, Class IA P13Ks convert phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol 3,4,5-trisphosphate (PIP3) upon growth factor stimulation. PIP3 recruits the serine/threonine kinases phosphoinositide-dependent kinase 1 (PDK1) and Akt to the membrane through their pleckstrin homology domains. Akt is then activated by phosphorylation at T308 by PDK1 and at S473 by PDK2 (Stokoe et al., 1997; Alessi et al., 1997a, b; Stephens et al., 1998; Sarbassov et al., 2004 Sarbassov et al., , 2005 . Activated Akt is the predominant and essential mediator for the regulation of both growth and proliferation by PI3K. Akt phosphorylates a broad spectrum of protein substrates that affect cell growth, survival and metabolism (Alessi and Cohen, 1998; Downward, 1998; Chan et al., 1999; Datta et al., 1999; Lawlor and Alessi, 2001; . Akt phosphorylates TSC2 at the residues S939, S1130 and T1462, thus inhibiting the GAP activity of the TSC complex and enhancing the charge of Rheb with GTP (Dan et al., 2002; Inoki et al., 2002 Inoki et al., , 2003 Manning et al., 2002; Castro et al., 2003; Garami et al., 2003; Tee et al., 2003; Zhang et al., 2003) . Activation of TOR by Rheb-GTP leads to phosphorylation and activation of ribosomal S6 kinase (S6K), and phosphorylation and inactivation of eukaryotic translation initiation factor eIF-4E-binding protein 1 (4E-BP1; Brown et al., 1994; Sabatini et al., 1994; Sabers et al., 1995) . Through its modification of S6K and 4E-BP1 activities, TOR controls the translation of numerous proteins that regulate cell growth.
Rheb binds to the TOR complex directly (Long et al., 2005a) , and recent observations suggest that it activates TOR by relieving an inhibitory interaction between TOR and FK506-binding protein 38 (Bai et al., 2007) . Withdrawal of amino acids inhibits the binding of Rheb to TOR, although it does not change the level of GTP bound to Rheb. Overexpressed Rheb can restore the TOR-dependent phosphorylation of S6K when amino acids are withdrawn (Long et al., 2005b) . In vertebrate cells Rheb with a high GTP:GDP ratio appears more effective in activating TOR than Rheb with lower GTP:GDP ratio, yet Rheb-GDP interacts with TOR more strongly than Rheb-GTP (Long et al., 2005a) . In fission yeast the opposite result has been obtained: constitutively active Rheb mutants interact more strongly with TOR than the wild type (wt) ones (Urano et al., 2005) . Rheb likely has other functions in addition to the control of TOR, as suggested by rapamycinresistant activities of Rheb (Saito et al., 2005) .
In some mammalian tumors and tumor cell lines, the level of Rheb transcripts is elevated (Gromov et al., 1995; Basso et al., 2005) , but overexpression of either wt or of a constitutively active Rheb mutant does not cause morphological or growth transformation of NIH 3T3 cells (Clark et al., 1997) . Here we show that a constitutively active Rheb has oncogenic potential and induces transformation of chicken embryonic fibroblasts (CEF) via activated TOR. The transforming activity requires localization of Rheb to a cellular membrane.
Results
Rheb mutants that constitutively bind GTP induce oncogenic transformation in cell culture Ras, a close relative of Rheb, is mutationally activated by a glutamine to leucine substitution at position 61 (Q61L). The mutated Ras is insensitive to the GTPase-activating protein, is constitutively charged with GTP and is permanently active. Rheb has a conserved glutamine at position 64 in a homologous region of the protein. The Rheb Q64L mutant behaves similar to its Ras counterpart; it is nearly 90% bound to GTP (Inoki et al., 2003; Li et al., 2004; Long et al., 2005a) . The activity of the Rheb mutant, measured indirectly by the kinase level of its downstream target TOR, is substantially elevated (Li et al., 2004; Long et al., 2005a) . In addition to the Q64L mutant, several novel hyperactive mutants of Rheb were recently identified (Urano et al., 2005; Yan et al., 2006) . The mutants identified in S. pombe carry single aminoacid changes (V17G, S21G, K120R, N153T) that confer resistance to canavanine, a toxic arginine analogue. These mutations lower the affinity of the Rheb protein to GDP, thus increasing the ratio of Rheb-GTP to Rheb-GDP in the cell. We introduced the gain-of-function mutations singly into the sequence of the human wt Rheb, generating Rheb V17G, S21G, Q64L, K120R and N153T. The mutant constructs were fused to a FLAG tag at the N terminus, cloned into the avian retroviral expression vector RCAS (replication-competent ASLV Long terminal repeat (LTR) with a splice acceptor) and transfected into CEF. RCAS constructs produce infectious retrovirus upon transfection. This virus progeny was used to express the mutant Rheb proteins and study their properties. Western blot analysis confirmed RCASmediated expression of wt Rheb, Q64L ( Figure 1a ) and N153T (data not shown). The S21G mutant was expressed at a very low level, and V17G and K120R could not be detected in the infected cell cultures (data not shown). The mutants Q64L and N153T induced morphological changes characteristic of oncogenic transformation in monolayer cultures and conferred upon the infected cells the ability to produce colonies in nutrient agar (Figures 1b and c) . In contrast, CEF expressing wt Rheb showed only barely detectable changes in cell morphology and generated only few small colonies in soft agar (Figures 1b and c ). These results demonstrate the strong oncogenic potential of Q64L and N153T. We have chosen Q64L for further detailed investigation.
The morphological changes in CEF expressing Q64L include increased size and vacuolization (Figure 2a) . The average volume of the mutant-expressing cells as determined by a CASY Cell Counter (Scharfe System GmbH) is about 25% above that of cells expressing wt Rheb or vector alone (Figure 2b ). This result was confirmed by flow cytometry forward scatter analysis of fixed cells and by measurements with the Beckman Coulter Vi-CELL XR cell viability analyser. CEF transformed by Q64L also showed a 30% greater protein content than vector controls (Figure 2c ). Although Q64L-transformed cells have the ability of multilayered and anchorage-independent growth, showing altered morphology and increased protein content, their rate of propagation and cell-cycle profile do not significantly differ from those of wt Rheb or vector-only expressing cells (data not shown).
Cellular transformation induced by Rheb requires TOR activity Rheb binds to TOR and activates TOR in a GTPdependent manner (Long et al., 2005a) . In order to determine whether the oncogenic transformation induced by Q64L is TOR-dependent, we tested the effect of rapamycin, a specific inhibitor of TOR, on the transformation process. At a concentration of 10 ng/ml, rapamycin effectively interfered with the formation of transformed cell foci as well as with anchorageindependent growth induced by Q64L (Figure 3 ). This concentration of rapamycin had no effect on the transforming efficiency of the Jun oncoprotein tested in the same cells ( Figure 3b ). The experiments with rapamycin were complemented by determinations on TOR targets. Transient expression of Rheb in Drosophila S2 cells and HEK293 cells increases the phosphorylation of S6K and 4E-BP1, both targets of TOR (Castro et al., 2003; Garami et al., 2003; Inoki et al., 2003; Saucedo et al., 2003; Tee et al., 2003) . In serumstarved CEF, uninfected or infected with vector alone, phosphorylation of S6K was low, but insulin induced a strong phosphorylation on threonine 389 within 15 min. In contrast, CEF transformed by Q64L showed a high level of phosphorylation on threonine 389, even under conditions of serum deprivation, suggesting that S6K is constitutively activated in the Q64L-transformed cells (Figure 4) . Similarly, phosphorylation of 4E-BP1 was constitutively increased in Q64L-transformed cells but not in control cells. These results suggest that oncogenic transformation by Q64L depends on TOR activity and is correlated with constitutive activation of TOR signaling.
FOXO-1 and YB-1 interfere with the oncogenic transformation induced by Rheb
The winged helix transcription factor forkhead box protein class-O 1 (FOXO-1) is a growth-attenuating and pro-apoptotic protein. Phosphorylation of FOXO-1 by Akt induces exclusion of FOXO-1 from the nucleus, thus preventing its transcriptional activity and mediating its proteolytic degradation (Biggs et al., 1999; Cahill et al., 2001; . The Y box-binding protein 1 (YB-1) is a regulator of transcription and translation. It is transcriptionally downregulated in Akttransformed CEF, and ectopic expression of YB-1 induces a strong cellular resistance to transformation by constitutively active forms of PI3K and Akt (Bader et al., 2003) . Because FOXO-1 and YB-1 proteins are growth-inhibitory, we explored their potential for interference with Rheb-induced transformation. As shown in Figure 5 , both FOXO-1 and YB-1 dramatically reduced the anchorage-independent growth induced by Q64L. In contrast, the dominant negative Akt (dnAkt, T308A/S473A), which interferes with PI3K-induced oncogenic transformation (Aoki et al., 1998) but functions upstream of Rheb, does not inhibit Q64L-induced agar colony formation. These results are in accord with the canonical PI3K/Akt signaling pathway, which places Akt above and YB-1 below Rheb. The interference by FOXO-1 suggests that oncogenic activity of Rheb also requires signaling molecules that are regulated by FOXO-1.
Western blot analysis demonstrated that phosphorylation of Akt is downregulated in Q64L-transformed CEF (data not shown). This result agrees with previous findings and probably reflects a negative feedback regulation of Akt activity by TOR (Shah et al., 2004; Briaud et al., 2005; Hers and Tavare, 2005; Shah and Hunter, 2006; Wan et al., 2007) . Akt phosphorylates and thereby negatively regulates FOXO-1. Lower Akt activity in Q64L-transformed cells translates into less phosphorylation of and hence higher activity of FOXO-1 (data not shown). However, that activity may be insufficient to significantly affect the overexpressed Rheb mutant.
Cellular transformation by Rheb requires a functional membrane address Like other Ras family members, Rheb contains a C-terminal farnesylation motif, CAAX (where 'A' represents an aliphatic amino acid). Farnesylation of Rheb is essential for cell-cycle progression in S. pombe (Yang et al., 2001) , and is also required for arginine uptake in Saccharomyces cerevisiae (Urano et al., 2000) . In mammalian cells, loss of the farnesylation motif markedly reduces the ability of Rheb to induce TORdependent phosphorylation of S6K (Castro et al., 2003; Tee et al., 2003) . We determined the role of farnesylation in the transformation process induced by Q64L by constructing several mutants with a blocked or defective farnesylation signal, that is, Q64L-FLAG, FLAG-C181S, C181S-FLAG and Q64L/C181S-FLAG. We also generated mutants, myr-Q64L-FLAG and myr-Q64L/C181S-FLAG, with an inactive farnesylation motif but an added myristylation signal to test whether farnesylation-negative mutants can be rescued by providing an alternative membrane address. All mutants in which the farnesylation signal was either inactivated or blocked by a C-terminally fused FLAG tag failed to induce oncogenic transformation as measured by focus formation on monolayer culture and by anchorageindependent growth in nutrient agar ( Figure 6 ). Addition of a myristylation signal at the N-terminus of these mutants restored transforming activity ( Figure 6 ). The farnesylation-negative mutants also failed to induce the growth-factor independent phosphorylation of S6K and of 4E-BP1; myristylation rescued this signaling activity (Figure 7 ). These observations suggest that oncogenic transformation by Q64L requires membrane localization. This requirement is met by the C-terminal farnesylation signal of Rheb, but myristylation will serve the same function.
Observations with immunofluorescence directed to the FLAG tag showed that wt Rheb and Q64L are located in the cytoplasm, associated with vesicular structures (Figure 8a ). This cellular distribution is in agreement with recently published results (Takahashi et al., 2005; Buerger et al., 2006; Heo et al., 2006) . In addition, CEF expressing Q64L are characterized by pronounced cytoplasmic vacuolization, which has also been seen with wt Rheb in mammalian cells (Saito et al., 2005) . In contrast, the farnesylation-negative mutants Q64L-FLAG, FLAG-C181S, C181S-FLAG and Q64L/ C181S-FLAG showed identical patterns of localization: partially in the nucleus and partially in the cytoplasm (Figure 8a , FLAG-C181S is shown as representative for all these mutants). So far, no nuclear localization signal has been identified in Rheb. Addition of a myristylation signal at the N-terminus of these mutants, that is, 
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H Jiang and PK Vogt myr-Q64L-FLAG and myr-Q64L/C181S-FLAG, restored the cytoplasmic distribution and the association with vesicular structures. The constructs carrying a myristylation signal, myr-Q64L-FLAG and myr-Q64L/ C181S-FLAG, both induced the formation of conspicuous filopodia on the cell surface (Figure 8b ). Using antibodies raised against endoplasmic reticulum (ER)-specific protein ERp72, we found that wt Rheb, Q64L, myr-Q64L-FLAG and myr-Q64L/C181S-FLAG partially colocalized with ER but extended beyond the ER network. In contrast, FLAG-C181S showed much reduced association with ER ( Figure 8a ). Assays of protein binding to large multilamellar vesicles (LMVs) were conducted for wt Rheb, Q64L, C181S, and myr-Q64L/C181S. Compared to wt and Q64L, C181S showed much lower binding to phospholipids, whereas myr-Q64L/C181S showed much higher affinity for phospholipids than wt or Q64L (Figure 8c ).
Discussion
Constitutively active, GTP-bound Rheb has oncogenic potential; it transforms primary avian cells in culture and imparts on these cells the ability of anchorage- 
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independent growth. This growth-promoting activity of Rheb-GTP is of particular significance in view of the fact that Rheb is frequently overexpressed in various human cancer cells derived from carcinomas of the lung, colon and ovary (Gromov et al., 1995; Basso et al., 2005) . Rheb is also overexpressed in brain tumors (EC Holland, personal communication). The gain of function in Rheb may contribute to the malignant phenotype of the tumor cells. The Rheb-induced transformation in avian cell cultures is correlated with an increase in cell size and protein content, but it does not result in accelerated cell replication. The oncogenic activity of Q64L is probably not due to increased expression. At 10 days post transfection, there is no significant difference of protein levels between wt and Q64L, yet transformation is evident. However after Figure 6 Cellular transformation induced by myristylated mutant Ras-homolog enriched in brain (Rheb). In focus formation assay (round photographs), chicken embryonic fibroblasts (CEF) were infected with RCAS viruses expressing FLAG-Q64L, Q64L-FLAG, FLAG-C181S, Q64L/C181S-FLAG, myr-Q64L-FLAG or myr-Q64L/C181S-FLAG. The cultures were overlaid with nutrient agar and stained with crystal violet on day 14. In anchorage-independent colony formation assay (rectangular photographs), CEF were transfected with recombinant RCAS expressing FLAG-Q64L, Q64L-FLAG, FLAG-C181S, Q64L/C181S-FLAG, myr-Q64L-FLAG or myr-Q64L/C181S-FLAG. The cells were seeded in nutrient agar 12 days post transfection and photographed on day 10 after seeding. After three passages, they were seeded and challenged with Q64L expressed by RCAS(B). Equal amounts of cells were seeded in nutrient agar 10 days after challenge infection. Agar colonies were counted and photographed on day 10 after seeding. The result of one representative experiment is shown. Figure 7 Constitutive activation of target of rapamycin (TOR) signaling by myristylated mutant Ras-homolog enriched in brain (Rheb). Chicken embryonic fibroblasts (CEF) transfected with Q64L-FLAG, Q64L/C181S-FLAG, myr-Q64L-FLAG or myr-Q64L/C181S-FLAG were serum starved for 40 h and subsequently stimulated with insulin for 15 min. Cells were then lysed, and the proteins were separated on a 4-20% gradient Tris-glycine SDS-polyacrylamide gel. The transferred blot was probed with antibodies directed against total proteins or phosphorylated proteins as indicated.
Figure 8 Subcellular localization of Ras-homolog enriched in brain (Rheb). Chicken embryonic fibroblasts (CEF) expressing either (a) wild-type (wt) Rheb, Q64L, C181S (all with an N-terminal FLAG tag) or (b) myr-Q64L/C181S-FLAG were fixed in 3.7% formaldehyde and treated with mouse anti-FLAG and fluorescein isothiocyanate (FITC)-conjugated secondary antibody, or together with rabbit antiERp72 (Calbiochem) and Texas red-conjugated goat anti-rabbit antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Nuclei were stained with 4 0 6-Diamidino-2-phenylindole (DAPI). Pictures were taken with a Bio-Rad Radiance 2100 Rainbow confocal laser scanning microscope, attached to a Nikon TE2000-U microscope with infinity corrected optics. (c) Assays of protein binding to large multilamellar vesicles (LMVs). A mixture of brain phospholipids (10 mg/ml) was incubated with a protein sample from CEF transfected with wt Rheb, Q64L, C181S and myr-Q64L/C181S, respectively. The lipid-protein complex was spun down (designated as M for membrane-bound), whereas the cytosolic proteins in the supernatant (designated as C for cytosolic) was precipitated by trichloroacetic acid (TCA). Sample M and C were separated on a 4-20% Tris-Glycine SDS polyacrylamide gel. Blots were probed with anti-FLAG antibody and the intensity of the bands was quantified by the ImageJ software (NIH). The figure shows the ratios of membrane-bound to cytosolic proteins.
prolonged culture, Q64L is often expressed at higher levels than wt. This is likely due to an increase of protein synthesis in Q64L-transformed CEF. The GTPase activity of Q64L is sensitive to the GAP activity of TSC when both proteins are cotransfected (Li et al., 2004) . However, in the experiments described here, only Q64L is overexpressed by the RCAS vector, whereas TSC is endogenous. Under these conditions, the higher levels of Q64L will likely overcome endogenous TSC-GAP activity. Overexpression of wt Rheb might also overcome endogenous TSC-GAP activity, but its GTP/ GDP charge ratio is not high enough to trigger constitutive activation of TOR.
The growth promoting activity of Rheb is well documented in Drosophila, where wt Rheb enhances cell replication and induces an increase of cell size and where reduced or deleted Rheb function leads to cellcycle arrest (Patel et al., 2003; Saucedo et al., 2003; Stocker et al., 2003) . However, in mammalian NIH 3T3 cells, expression of constitutively active Rheb has not resulted in an altered phenotype (Clark et al., 1997) . Mammalian cells are refractory to the action of most single oncogenes; in contrast, avian cells are highly sensitive indicators of the oncogenic potential of single agents. They can be readily transformed by single oncoproteins, for example, Myc, Jun, Qin, P3K or Akt, all of which are either inactive or extremely inefficient as single oncogenic agents in mammalian cell systems (Bister et al., 1977; Chang et al., 1997; Aoki et al., 1998; Himly et al., 1998) .
Rheb is an essential component of the Akt/TOR signaling chain. The transforming activity of Rheb is highly sensitive to the TOR inhibitor rapamycin and therefore is TOR dependent. Accordingly, Rheb-induced transformation is correlated with enhanced phosphorylation of the TOR targets S6K and 4E-BP1. Yet not all activities of Rheb are mediated by TOR. Rheb interacts with the B-Raf kinase in a rapamycin-resistant manner and inhibits its function, resulting in an interference with H-Ras (G12V)-induced transformation of NIH 3T3 cells (Clark et al., 1997; Yee and Worley, 1997; Im et al., 2002; Karbowniczek et al., 2004 Karbowniczek et al., , 2006 . The pronounced vacuolization observed in Rheb-expressing cells by Saitc and co-workers and by us appears to reflect another TOR-independent function of Rheb (Saito et al., 2005) . Exposure of Rheb-transformed cells to rapamycin for extended periods (6-24 h) has no detectable effect on the extent of vacuolization but effectively shuts down TOR activity within 2 h as judged by phosphorylation of S6K and 4E-BP1 (data not shown).
We have identified two effective antagonists of the growth-promoting activity of Rheb, YB-1 and FOXO-1. Both interfere with Rheb-induced oncogenic transformation. YB-1 is transcriptionally downregulated in Akttransformed cells, and re-expression of YB-1 induces a strong cellular resistance to Akt signaling and to Aktdependent transformation (Bader et al., 2003) . This effect of YB-1 is probably due to an inhibition of capdependent protein synthesis Vogt, 2005, 2008) . The inhibition appears to be selective for certain growth-stimulating proteins generated from messages with complex 5 0 untranslated structures that require an abundance of eIF4E (eukaryotic initiation factor 4E) for effective translation. YB-1 acts downstream of TOR, and its inhibitory action of Rheb-induced transformation is in accord with the position of Rheb in the Akt signaling pathway. The inhibitory effect of FOXO-1 on Rheb-induced transformation is likely the result of FOXO-1-induced enhancement in the transcription of GADD45 and of p27Kip, two negative regulators of the cell cycle (Medema et al., 2000; Furukawa-Hibi et al., 2002; Stahl et al., 2002; Cunningham et al., 2004) . The antagonistic effect of YB-1 on Rheb is specific for the Akt-TOR signaling pathway; that of FOXO-1 will likely extend to a broad spectrum of oncoproteins, representing different signaling pathways. As expected, dominant-negative Akt does not interfere with Rhebinduced transformation. Akt is situated upstream of Rheb, and constitutively active Rheb functions independently of Akt. In Rheb-transformed cells, phosphorylation of serine 473 and threonine 308 of Akt is significantly reduced (data not shown). Whether this reduction translates into attenuated Akt activity is not known.
Oncogenic transformation by Rheb requires a functional farnesylation signal. Expression of constructs with a mutated or blocked farnesylation signal has no detectable effect on the cellular phenotype. However, such constructs can be rescued with the addition of an N-terminal myristylation signal. The functional equivalence of myristylation and farnesylation suggests the relevant effect of these post-translational modifications of Rheb is membrane localization. It is not known whether attachment to any cellular lipid membrane satisfies this requirement or whether a functionally specialized membrane has to be addressed. Location of Rheb by immunofluorescence suggests an at least partial overlap with ER. In our experiments Rheb is overexpressed, and it is therefore not surprising that its distribution exceeds the areas defined by the ER-specific marker. The mandatory association of Rheb with cellular membranes is likely to extend to TOR. Rheb physically interacts with TOR and therefore could recruit TOR to a membrane. The subcellular localization of TOR is likely signal dependent and cells observed under different conditions yield different results. Although a nuclear localization has been reported for TOR (Zhang et al., 2002) , TOR has also been found in the cytoplasm and might shuttle between cytoplasm and nucleus (Sabatini et al., 1999; Kim and Chen, 2000) . Drenan et al. demonstrate a predominantly perinuclear distribution of TOR and show a close association with ER and the Golgi apparatus (Drenan et al., 2004) . Our data then suggest that the intracellular membranes composed of the ER and the Golgi network might offer a platform for Rheb and TOR to interact in signal transduction.
In summary, our studies reveal an oncogenic potential of Rheb that is dependent on both TOR activity and binding to a cellular membrane. The overexpression of Rheb in human gliomas suggests that it may be a therapeutically valuable target.
Materials and methods

Plasmid construction
Human Rheb (hRheb) gene (AF493921) was obtained from Openbiosystems (Huntsville, AL, USA). Kozak sequence and FLAG tag were introduced into hRheb by PCR using primers 5 0 -AGCTCCGCGGGCCACCATGGACTACAAGGATGACG ATGACAAGCCGCAGTCCAAGTCCCGGAAGA-3 0 , and 5 0 -AGCTTCTAGATCACATCACCGAGCATGAAG-3 0 . PCRamplified Rheb was subsequently cloned into pBSFI vector (Aoki et al., 1998) , then the SfiI DNA fragment was cloned into the avian retrovirus vector RCAS(B).Sfi (Hughes et al., 1987; Ahmed et al., 1997) . For C-terminally FLAG-tagged Rheb, primers 5 0 -ACTGGCGGCCGCGCCACCATGCCGCAGTCC AAGTCCCG-3 0 and 5 0 -TGCCACGCGTTCACTTGTCATC GTCATCCTTGTAGTCCATCACCGAGCATGAAGACT-3 0 were used. The mutant constructs containing a V17G, S21G, Q64L, K120R, N153T substitution were generated by using the Quick Change site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA) and the following primers:
. For myr-Rheb, myristylation signal was added at the 5 0 -end and FLAG was added at the 3 0 -end using primers 5 0 -ACTGGCGGCCGCGCCACCATGGGGAGCAGCAAGAG CAAGCCCAAGGACCCCAGCCAGCGCCCGCAGTCCA AGTCCCGGAA-3 0 , and 5 0 -TGCCACGCGTTCACTTGT CATCGTCATCCTTGTAGTCCATCACCGAGCATGAAG ACT-3 0 . Farnesylation mutant C181S was constructed using primers 5 0 -FLAG-C181S (5 0 -ACTGGCGGCCGCGCCACCA TGGACTACAAGGATGACGATGACAAGCCGCAGTCC AAGTCCCGGAA-3 0 ) and 3 0 -FLAG-C181S (5 0 -TGCCA CGCGTTCACATCACCGACGATGAAGACTTGCCTTGT GAAG-3 0 ).
Cell culture and transformation assays Primary cultures of CEF were prepared from White Leghorn embryos obtained from Charles River Breeding Laboratories (Preston, CT, USA). For focus assays with infectious retroviral vectors, DNA was transfected into CEF by using the dimethyl sulfoxide-polybrene method (Duff and Vogt, 1969; Bos et al., 1990; Chang et al., 1997) . CEF were infected with culturing medium containing the RCAS vector or recombinant RCAS viruses. The cultures were overlaid with nutrient agar and stained with crystal violet on day 14. Rapamycin (Calbiochem, La Jolla, CA, USA) was added directly to the nutrient agar overlay of the infected cells. Controls received dimethyl sulfoxide vehicle instead of rapamycin. Infected cells were fed every other day with nutrient agar for 14 days and stained with crystal violet. The ability of cells to grow in soft nutrient agar suspension was tested according to published techniques (Himly et al., 1998; Cohen et al., 2001; Sonderegger and Vogt, 2003) . Colonies were counted after 14 days of incubation. Pictures were taken using a Zeiss Axiovert 35 microscope and a Canon 300D digital camera. Mean cell size was determined by a CASY Cell Counter (Scharfe System GmbH) with live cells, or by flow cytometry forward scatter analysis of fixed cells, or by a Beckman Coulter Vi-CELL XR cell viability analyser. Fluorescence-activated cell sorting analysis was following standard procedures.
Serum starvation and insulin stimulation
For serum starvation, CEF were cultured in Ham's F-10 medium (Sigma, St Louis, MO, USA) containing 0.5% fetal calf serum and 0.1% chicken serum for 40 h. Then the cells were stimulated with 10 nM insulin (Sigma) for 15 min. For rapamycin treatment, rapamycin (10 ng/ml) was added to the culture 2 h before the addition of insulin.
Western blot analysis CEF were grown to confluence, rinsed with phosphatebuffered saline (PBS), and lysed in protein lysis buffer containing 1% Nonidet P-40, 10% glycerol, 20 mM Tris (pH 7.4), 150 mM NaCl, 1 mM MgCl 2 , 1 mM PMSF, 50 mM NaF, 1 mM DTT, 50 mM b-glycerophosphate, 1 mM Na 3 VO 4 and 1 Â Complete protease inhibitor mixture (Roche, Pleasanton, CA, USA). Lysates containing 30-40 mg of protein were separated on a 4-20% Tris-Glycine SDS polyacrylamide gel (Invitrogen, Carlsbad, CA, USA), and transferred to an Immobilon P membrane (Millipore, Billerica, MA, USA).
The membrane was blocked with 5% nonfat dry milk in 0.1% Tween-20 in 1 Â Tris-buffered saline (TBS-T) for 1 h at room temperature and incubated overnight at 4 1C with primary antibodies (5% bovine serum albumin in 0.1% TBS-T for polyclonal antibody, and 5% nonfat dry milk in 0.1% TBS-T for monoclonal antibody). After rinsing with 0.1% TBS-T, the blots were incubated with secondary antibodies in 5% nonfat dry milk/0.1% TBS-T for 1 h at room temperature. The reactive bands were visualized by chemiluminescence (Pierce, Rockford, IL, USA). Anti-Akt, anti-phospho-Akt (Ser-473, and Thr-308), anti-S6K, anti-phospho-S6K (Thr-389), anti-4E-BP1, anti-phospho-4E-BP1 (Ser-65), anti-FOXO-1, antiphospho-FOXO-1 (Ser-256) antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA), anti-tubulin antibody from ICN (Costa Mesa, CA, USA), anti-FLAG antibody from Sigma.
Protein binding to large multilamellar vesicles
Assays of protein binding to LMVs follow the procedure described in a previous publication (Davletov et al., 1998) . A mixture of brain phospholipids (10 mg/ml; Avanti Polar Lipids Inc., Alabaster, AL, USA) was vortexed to form LMVs. A 100 mg protein sample prepared with passive lysis buffer (Promega, Madison, WT, USA) was mixed with 320 mg lipids and diluted into 500 ml 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)/NaCl buffer (50 mM HEPES, 100 mM NaCl, pH 7.2). After 15 min incubation at room temperature, the lipids were spun down with associated proteins at 10 700 r.p.m. for 10 min. The pellet, designated as M for membrane-bound, was washed once with the HEPES/NaCl buffer and dissolved in protein sample buffer, whereas the supernatant was transferred to another tube and an equal volume of 40% trichloroacetic acid was added and further incubated on ice for 15 min. This portion of cytosolic proteins, designated as C for cytosolic, was spun down and washed with 500 ml HEPES/NaCl buffer, then dissolved in protein sample buffer. Sample M and C were separated on a 4-20% TrisGlycine SDS polyacrylamide gel. Blots were probed with anti-FLAG antibody and the intensity of the bands was quantified by the ImageJ software (NIH). The ratios of membrane-bound to cytosolic proteins are shown in Figure 8c .
Immunofluorescence Cells grown overnight on glass coverslips were washed once with PBS, fixed with 3.7% formaldehyde for 30 min, and permeabilized with PBS containing 0.1% Triton X-100 (Sigma) for 30 min. After a wash with PBS, the coverslips were incubated with 10% goat serum (Sigma) for 1 h at room temperature in a humidified container followed by incubation with mouse monoclonal anti-FLAG antibody (Sigma) for another hour. Coverslips were washed with PBS three times and incubated with fluorescein isothiocyanate-conjugated goat anti-mouse immunoglobulin G (Sigma) for 1 h. During the last 5 min, 4 0 6-diamidino-2-phenylindole (DAPI) was added. The coverslips were again washed three times with PBS and mounted on glass slides using Slowfade mounting medium (Molecular Probes, Eugene, OR, USA). Primary and secondary antibodies were used at a final dilution of 1:100, and the final concentration of DAPI was 2 ng/ml. Anti-ERp72 and anti-GRASp65 antibodies were purchased from Calbiochem. Pictures were taken with confocal laser scanning microscopy.
Abbreviations 4E-BP1, eukaryotic initiation factor 4E-binding protein 1; Akt, v-akt murine thymoma viral oncogene homolog; CEF, chicken embryonic fibroblast; eIF4E, eukaryotic initiation factor 4E; ER, endoplasmic reticulum; FOXO-1, forkhead box protein class-O 1; GAP, GTPase-activating protein; PI3K, phosphatidylinositol 3-kinase; PIP3, phosphatidylinositol 3,4,5-trisphosphate; Ras, rat sarcoma; Rheb, Ras-homolog enriched in brain; S6K, ribosomal protein S6 kinase; TOR, target of rapamycin; TSC, tuberous sclerosis complex; YB-1, Y box-binding protein 1.
